Natera, Aveta Biomics collaborate on head and neck cancer trial

Natera and Aveta Biomics have entered into a strategic partnership to support the latter’s AVTA 30-01, a global Phase III head and neck cancer trial assessing APG-157 in patients with LA-HNSCC.

The post Natera, Aveta Biomics collaborate on head and neck cancer trial appeared first on Hospital Management.

 

Back to the Featured Stories

Connect with us

Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.